Safety, Tolerability and Pharmacokinetics of SH-1028 in Patients With Advanced NSCLC
Clinical trial NCT03603262 · UNKNOWN
Trial details
- NCT number
- NCT03603262
- Sponsor
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-25
- Primary completion
- 2019-12-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.